Schedule 13G ownership disclosure
MARINUS PHARMACEUTICALS INC
Common Stock · CUSIP: 56854Q200
Event date: 2024-12-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Beryl Capital Management LLC
Shares: 5,462,942.00 · Class: 9.9%
- Beryl Capital Management LP
Shares: 5,462,942.00 · Class: 9.9%
- Beryl Capital Partners II LP
Shares: 4,801,329.00 · Class: 8.7%
- David A. Witkin
Shares: 5,462,942.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000032
- Form type
- SCHEDULE 13G
- Filer
- Beryl Capital Management LLC
- CIK
- CIK 1719307
- Filed
- Jan 07, 2025
- Reporting period
- Dec 30, 2024
- Description
- Schedule 13G beneficial ownership